Prosight Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,000
Closed -$66.9K 46
2023
Q1
$66.9K Sell
9,000
-280,335
-97% -$1.55M 0.03% 40
2022
Q4
$1.43M Buy
+289,335
New +$1.79M 0.78% 28
2021
Q4
Sell
-38,774
Closed -$562K 46
2021
Q3
$562K Buy
+38,774
New +$747K 0.31% 39

Other funds holding LFST

Prosight Management's LFST Position: Q2 2023 in Review

Prosight Management sold out of Lifestance Health (LFST) in Q2 2023, closing a stake of 9,000 shares — an estimated $66.9K sold.

Prosight Management first reported a position in LFST in Q3 2021 and held it in 3 quarters. The position peaked at $1.43M in Q4 2022. 109 funds tracked by Wall St. Rank hold LFST as of Q2 2023.

  • Prosight Management reported no remaining Lifestance Health position as of Q2 2023 after selling out during the quarter.
  • Prosight Management sold 9,000 Lifestance Health shares in Q2 2023, an estimated $66.9K.
  • Prosight Management first reported a position in Lifestance Health in Q3 2021 and held it in 3 quarters.
  • Prosight Management's Lifestance Health position peaked at $1.43M in Q4 2022.
  • 109 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2023.

Based on Prosight Management's 13F filing for Q2 2023, filed 14 Aug 2023.